SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M.E. Glover, P.C. Pugh, N.L. Jackson, J.L. Cohen, A.D. Fant, H. Akil, S.M. Clinton, Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats, Neuroscience, 2015, 284, 775

    CrossRef

  2. 2
    RA Charlton, S Jordan, A Pierini, E Garne, AJ Neville, AV Hansen, R Gini, D Thayer, K Tingay, A Puccini, HJ Bos, AM Nybo Andersen, M Sinclair, H Dolk, LTW Jong-van den Berg, Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions, BJOG: An International Journal of Obstetrics & Gynaecology, 2015, 122, 5
  3. 3
    Suni Jani, Sophia Banu, Asim A. Shah, SSRI Use During Pregnancy and Autism: Is It a Real Threat?, Psychiatric Annals, 2015, 45, 2, 83

    CrossRef

  4. 4
    Jocelien D. A. Olivier, Helena Åkerud, Alkistis Skalkidou, Helena Kaihola, Inger Sundström-Poromaa, The effects of antenatal depression and antidepressant treatment on placental gene expression, Frontiers in Cellular Neuroscience, 2015, 8,

    CrossRef

  5. 5
    Katherine L Wisner, Christof Schaefer, Drugs During Pregnancy and Lactation, 2015,

    CrossRef

  6. 6
    M. M. H. J. van Gelder, L. T. W. de Jong-van den Berg, N. Roeleveld, Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks, Human Reproduction, 2014, 29, 1, 168

    CrossRef

  7. 7
    Nicole E De Long, Nicole G Barra, Daniel B Hardy, Alison C Holloway, Is it safe to use smoking cessation therapeutics during pregnancy?, Expert Opinion on Drug Safety, 2014, 13, 12, 1721

    CrossRef

  8. 8
    Bjarke Askaa, Espen Jimenez-Solem, Henrik Enghusen Poulsen, Jon Traerup Andersen, Maternal Characteristics of Women Exposed to Hypnotic Benzodiazepine Receptor Agonist during Pregnancy, Obstetrics and Gynecology International, 2014, 2014, 1

    CrossRef

  9. 9
    Hanan El Marroun, Tonya White, Frank C. Verhulst, Henning Tiemeier, Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review, European Child & Adolescent Psychiatry, 2014, 23, 10, 973

    CrossRef

  10. 10
    Shona Ray, Zachary N. Stowe, The use of antidepressant medication in pregnancy, Best Practice & Research Clinical Obstetrics & Gynaecology, 2014, 28, 1, 71

    CrossRef

  11. 11
    Jun Wu, Mary Lynn Davis-Ajami, Sharon Keiser, Lynda Sykes, Antidepressant Prescription Medication Use Patterns among Insured, Low Income Pregnant Women, American Journal of Public Health Research, 2013, 1, 3, 72

    CrossRef

  12. You have free access to this content12
    Kara N. D. Polen, Sonja A. Rasmussen, Tiffany Riehle-Colarusso, Jennita Reefhuis, Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997–2007, Birth Defects Research Part A: Clinical and Molecular Teratology, 2013, 97, 1
  13. 13
    P. G. J. ter Horst, H. J. Bos, L. T. W. de Jong-van de Berg, B. Wilffert, In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children, European Journal of Clinical Pharmacology, 2013, 69, 3, 541

    CrossRef

  14. 14
    H. M. Jensen, R. Gron, O. Lidegaard, L. H. Pedersen, P. K. Andersen, L. V. Kessing, Maternal depression, antidepressant use in pregnancy and Apgar scores in infants, The British Journal of Psychiatry, 2013, 202, 5, 347

    CrossRef

  15. 15
    Rebecca A. Harrington, Li-Ching Lee, Rosa M. Crum, Andrew W. Zimmerman, Irva Hertz-Picciotto, Serotonin Hypothesis of Autism: Implications for Selective Serotonin Reuptake Inhibitor Use during Pregnancy, Autism Research, 2013, 6, 3
  16. 16
    Hans Mørch Jensen, Randi Grøn, Øjvind Lidegaard, Lars Henning Pedersen, Per Kragh Andersen, Lars Vedel Kessing, The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age, Psychopharmacology, 2013, 228, 2, 199

    CrossRef

  17. 17
    Geert W. ‘t Jong, Thomas Einarson, Gideon Koren, Adrienne Einarson, Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): A systematic review, Reproductive Toxicology, 2012, 34, 3, 293

    CrossRef

  18. 18
    Luke E. Grzeskowiak, Andrew L. Gilbert, Janna L. Morrison, Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy, European Journal of Clinical Pharmacology, 2012, 68, 5, 459

    CrossRef

  19. 19
    Sharron S.K. Leung, T.H. Lam, Group antenatal intervention to reduce perinatal stress and depressive symptoms related to intergenerational conflicts: A randomized controlled trial, International Journal of Nursing Studies, 2012, 49, 11, 1391

    CrossRef

  20. 20
    Luke E. Grzeskowiak, Andrew L. Gilbert, Janna L. Morrison, Neonatal Outcomes After Late-Gestation Exposure to Selective Serotonin Reuptake Inhibitors, Journal of Clinical Psychopharmacology, 2012, 32, 5, 615

    CrossRef

  21. 21
    Chagit Klieger-Grossmann, Brenda Weitzner, Alice Panchaud, Alessandra Pistelli, Thomas Einarson, Gideon Koren, Adrienne Einarson, Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study, The Journal of Clinical Pharmacology, 2012, 52, 5
  22. 22
    L. E. Grzeskowiak, A. L. Gilbert, J. L. Morrison, Prenatal exposure to selective serotonin reuptake inhibitors and risk of childhood overweight, Journal of Developmental Origins of Health and Disease, 2012, 3, 04, 253

    CrossRef

  23. 23
    Coleen A. Boyle, José F. Cordero, Edwin Trevathan, The National Center on Birth Defects and Developmental Disabilities, American Journal of Preventive Medicine, 2012, 43, 6, 655

    CrossRef

  24. 24
    Kyle Davis, Sona Dimidjian, The Relationship Between Physical Activity and Mood Across the Perinatal Period: A Review of Naturalistic and Clinical Research to Guide Future Investigation of Physical Activity–Based Interventions for Perinatal Depression, Clinical Psychology: Science and Practice, 2012, 19, 1
  25. 25
    Cesario Bellantuono, Francesca Bozzi, Laura Orsolini, Mario Catena-Dell'Osso, The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review, Human Psychopharmacology: Clinical and Experimental, 2012, 27, 6
  26. 26
    Arzneimittel in Schwangerschaft und Stillzeit, 2012,

    CrossRef

  27. 27
    Ariela Frieder, Antidepressant use during pregnancy, Expert Review of Obstetrics & Gynecology, 2011, 6, 3, 285

    CrossRef

  28. 28
    CATHERINE MONK, ELIZABETH M. FITELSON, ELIZABETH WERNER, Mood Disorders And Their Pharmacological Treatment During Pregnancy: Is the Future Child Affected?, Pediatric Research, 2011, 69, 5 Part 2, 3R

    CrossRef

  29. 29
    Miia Artama, Mika Gissler, Heli Malm, Annukka Ritvanen, Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996–2006, Pharmacoepidemiology and Drug Safety, 2011, 20, 7
  30. 30
    Ellen Mozurkewich, Julie Chilimigras, Chelsea Klemens, Kristie Keeton, Lucy Allbaugh, Susan Hamilton, Deborah Berman, Delia Vazquez, Sheila Marcus, Zora Djuric, Anjel Vahratian, The mothers, Omega-3 and mental health study, BMC Pregnancy and Childbirth, 2011, 11, 1, 46

    CrossRef